MedPath
NMPA Approval

Compound Aminophenazone and Barbital Injection

国药准字H41025444

March 14, 2023

Drug Information

复方氨林巴比妥注射液

注射剂

2ml

化学药品

March 14, 2023

Company Information

Applicant Company

焦作市建设东路168号

Manufacturing Company

焦作市建设东路168号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

复方氨林巴比妥注射液 - NMPA 批准文号 | MedPath